Page last updated: 2024-12-06

pumitepa

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pumitepa: structure; RN given refers to unlabeled cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID68669
CHEMBL ID507584
SCHEMBL ID18755
MeSH IDM0065514

Synonyms (23)

Synonym
fopurine
brn 1036986
fopurin
p,p-bis(1-aziridinyl)-n-(2-(dimethylamino)-7-methyl-7h-purin-6-yl)phosphinic amide
phopurine
pumitepa
2-dimethylamino-6-diethyleniminophosphamido-7-methylpurine
p,p-bis(1-aziridinyl)-n-(2-(dimethylamino)-7-methylpurin-6-yl)phosphinic amide
pumitepum [latin]
pumitepa [inn]
phopurinum
phosphinic amide, p,p-bis(1-aziridinyl)-n-(2-(dimethylamino)-7-methyl-7h-purin-6-yl)-
2-dimethylamino-6-diethylenimidophosphamido-7-methylpurine
6-n-[bis(aziridin-1-yl)phosphoryl]-2-n,2-n,7-trimethylpurine-2,6-diamine
CHEMBL507584
42061-52-9
unii-7ayy495re0
7ayy495re0 ,
pumitepum
SCHEMBL18755
1-methylindole-2-carboxaldehyde97
Q16712382
DTXSID10866073

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The mechanisms of modifications were examined by pharmacokinetic techniques."( [The pharmacokinetic modification of mutagenesis].
BratslavskiÄ­, VA; Revazova, IuA, 1993
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID409958Inhibition of bovine brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (63.64)18.7374
1990's3 (27.27)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.44 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.08 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (7.69%)4.05%
Observational0 (0.00%)0.25%
Other12 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]